DUX4 and facioscapulohumeral muscular dystrophy: To better understand the immune responses and immune cell profile in FSHD skeletal muscles, we used the FSHD-like bi-transgenic mouse line ACTA1-MCM;FLExD, which, in the absence of tamoxifen induction, is a well-established model of chronic DUX4 expression.